What is the main purpose of this 10-Q filing?

The main purpose of this 10-Q filing is to provide investors and the public with Johnson & Johnson's financial performance and significant business developments for the quarterly period ending March 29, 1997. It is a mandatory SEC filing that ensures transparency in corporate financial reporting.

Where can I find the detailed financial results for Johnson & Johnson from this filing?

The provided text is a directory listing from the SEC's EDGAR system and does not contain the actual financial statements or management's discussion and analysis. To access the detailed financial results, you would need to retrieve and review the full 10-Q document (likely the .txt or a linked HTML version) through the SEC's EDGAR database.

What kind of information is typically included in a 10-Q filing besides financial statements?

A 10-Q filing typically includes unaudited financial statements (balance sheets, income statements, cash flow statements), Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A), legal proceedings, risk factors, and disclosures about any material changes in internal controls. It also often includes updates on any previously disclosed significant events.

What does the filing date of May 8, 1997, tell me about the reporting period ending March 29, 1997?

The filing date of May 8, 1997, indicates that Johnson & Johnson submitted its report approximately 40 days after the end of its first fiscal quarter. This timeframe is typical for 10-Q filings, allowing companies sufficient time to compile and review their financial information before public release.

JNJ 10-Q Quarterly Report Q1 FY1997 — Revenue, Net Income, EPS

Summary

Johnson & Johnson's (JNJ) 10-Q filing for the period ending March 29, 1997, indicates a company operating within a well-established regulatory framework, as evidenced by the filing's presence on the SEC's EDGAR system. While specific financial performance data for the quarter is not directly accessible from the provided directory listing, the filing signifies JNJ's commitment to transparency and regular financial reporting to its investors. Investors should look to the full text of the 10-Q filing itself for detailed financial statements, management's discussion and analysis, and any material events or risks that may have impacted the company during this reporting period.

Key Highlights

1Filing Period: The report covers the quarterly period ending March 29, 1997.
2Filing Date: The report was officially filed with the SEC on May 8, 1997.
3Company: The filing is for Johnson & Johnson (JNJ).
4Filing Type: This is a Quarterly Report on Form 10-Q.
5Regulatory Compliance: The filing demonstrates JNJ's adherence to SEC reporting requirements.
6EDGAR System: The report is accessible through the SEC's Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system, ensuring public availability.
7Limited Detail in Listing: The provided directory listing does not contain the detailed financial statements or narrative disclosures typically found within the full 10-Q document.

JOHNSON & JOHNSON Quarterly Report for Q1 Ended Mar 30, 1997

Summary

Key Highlights

Frequently Asked Questions